TSHA Operating Cash Flow (Statement)
Taysha Gene Therapies Inc · Operating Cash Flow (Statement)
TSHA Operating Cash Flow (Statement)
Latest reported-$132.19Mperiod ending
TSHA Cash from Operations ($135.00K → -$132.19M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TSHA operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -93,090,000 | |
| -81,225,000 | |
| -73,018,000 | |
| -88,390,000 | |
| -117,042,000 | |
| -30,729,000 | |
| 135,000 |